clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Myxoma D009232 1 associated lipids
Kleine-Levin Syndrome D017593 1 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Gui J et al. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing]. 2013 Zhonghua Jie He He Hu Xi Za Zhi pmid:24252731
AvÅŸar E et al. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. 2013 Turk J Gastroenterol pmid:24254262
Smiley R et al. Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori. 2013 J. Microbiol. pmid:24173641
Morgan DR et al. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. 2013 JAMA pmid:23403682
Naserpour Farivar T et al. Prevalence of clarithromycin-resistant Helicobacter pylori in patients with chronic tonsillitis by allele-specific Scorpion real-time polymerase chain reaction assay. 2013 Laryngoscope pmid:23404672
Koh WJ et al. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. 2013 Antimicrob. Agents Chemother. pmid:23478956
Ohe M and Hashino S Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide. 2013 Korean J. Intern. Med. pmid:23682236
Sadeghifard N et al. Survey in Iran of clarithromycin resistance in Helicobacter pylori isolates by PCR-RFLP. 2013 Southeast Asian J. Trop. Med. Public Health pmid:23682442
Togami K et al. Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro. 2013 Biol. Pharm. Bull. pmid:23995662
Liu X et al. Clarithromycin-loaded liposomes offering high drug loading and less irritation. 2013 Int J Pharm pmid:23337631
Kim MS et al. Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea. 2013 Helicobacter pmid:23066652
Markert C et al. Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1. 2013 Eur. J. Clin. Pharmacol. pmid:23748747
Faraji F et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. 2012 Nov-Dec Pain Physician pmid:23159967
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Singh V et al. Vesicular palmoplantar pityriasis rosea. 2012 Mar-Apr Skinmed pmid:22545332
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Rajendiran S et al. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. 2012 Jul-Aug Saudi J Gastroenterol pmid:22824768
De Sanctis V et al. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. 2012 Jul-Aug Tumori pmid:23052174
Figueroa M et al. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. 2012 Jan-Mar Biomedica pmid:23235785
de Lalibera IB et al. Meningoencephalitis associated with Mycoplasma pneumoniae. 2012 Jan-Mar Einstein (Sao Paulo) pmid:23045836
Dhillon GS et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. 2012 Jan-Feb Clin Transplant pmid:21352378
Onsun N et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. 2012 Jan-Feb Eur J Dermatol pmid:22063790
Montero-Tinnirello J et al. [Pulmonary hemorrhage due to leptospirosis]. 2012 Jan-Feb Med Intensiva pmid:21592620
Dai WQ et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. 2012 Jan-Feb Hepatogastroenterology pmid:22260837
Shojaei H et al. Chronic pulmonary disease due to Mycobacterium monacense infection: the first case from Iran. 2012 Ann Lab Med pmid:22259785
Kim SY et al. Pulmonary infection caused by Mycobacterium conceptionense. 2012 Emerging Infect. Dis. pmid:22257692
Malfertheiner P et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 2012 Gut pmid:22491499
Seddon G et al. Drug design for ever, from hype to hope. 2012 J. Comput. Aided Mol. Des. pmid:22252446
Huang YK et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. 2012 J Dig Dis pmid:22435509
Choi SJ et al. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. 2012 Ann Lab Med pmid:22563554
Bowers JR et al. Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona. 2012 BMC Microbiol. pmid:22251616
Brož P et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. 2012 Allergy pmid:22435670
Sharma H et al. Fortuitous vasculitis. 2012 Ren Fail pmid:22250755
Hojsak I et al. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience. 2012 Eur. J. Pediatr. pmid:22430353
Koutsoubari I et al. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. 2012 Pediatr Allergy Immunol pmid:22433020
Lin YH and Liu TC Mycobacterium chelonae infection involving the auricle. 2012 QJM pmid:21908384
Padovan J et al. Investigating the barriers to bioavailability of macrolide antibiotics in the rat. 2012 Eur J Drug Metab Pharmacokinet pmid:22113743
Ji R et al. Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. 2012 Gastrointest. Endosc. pmid:22325805
Barberán J et al. Update on the clinical utility and optimal use of cefditoren. 2012 Int J Gen Med pmid:22675264
Kumar R et al. Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens. 2012 Bioorg. Med. Chem. Lett. pmid:22153939
Matsueda K et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. 2012 Gut pmid:22157329
Togami K et al. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. 2012 J Aerosol Med Pulm Drug Deliv pmid:22360316
Shiotani A et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. 2012 J. Gastroenterol. pmid:22382634
Ding FM et al. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. 2012 Respirology pmid:22404374
Kadayifci A et al. Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection. 2012 Helicobacter pmid:22404442
Gisbert JP and McNicholl AG Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital. 2012 Helicobacter pmid:22404448
Salmon JH et al. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation. 2012 Joint Bone Spine pmid:22405857
Alzolibani AA and Zedan K Macrolides in chronic inflammatory skin disorders. 2012 Mediators Inflamm. pmid:22685371
Masekela R and Green RJ The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. 2012 Mediators Inflamm. pmid:22570510
Konorev MR [Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy]. 2012 Ter. Arkh. pmid:23479993
Inamo Y et al. A 7-year-old girl with subcutaneous emphysema, pneumomediastinum, pneumothorax, and pneumoretroperitoneum caused by Mycoplasma pneumoniae pneumonia. 2012 J. Infect. Chemother. pmid:21901497
Lee MR et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. 2012 J. Antimicrob. Chemother. pmid:21980068
Cuadrado-Lavín A et al. Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. 2012 J. Antimicrob. Chemother. pmid:21965436
Ivetic Tkalcevic V et al. Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. 2012 Transl Res pmid:22677362
Ngan LT et al. Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori. 2012 J. Agric. Food Chem. pmid:22891951
Kao SS et al. 7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan. 2012 Gastroenterol Res Pract pmid:22888337
Shah M et al. Transient Psychotic Episode Induced by Helicobacter pylori Triple Therapy Treatment. 2012 Case Rep Gastroenterol pmid:22855656
Heeb F et al. Organic micropollutants in rivers downstream of the megacity Beijing: sources and mass fluxes in a large-scale wastewater irrigation system. 2012 Environ. Sci. Technol. pmid:22845779
Wu W et al. Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication. 2012 Gastroenterol Res Pract pmid:22829809
Shih HY et al. Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population. 2012 Gastroenterol Res Pract pmid:22829808
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
O'Connor MB et al. Rituximab-induced pulmonary disease. 2012 Rheumatol. Int. pmid:21892654
Nakagawa T et al. [Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium]. 2012 Kekkaku pmid:23367826
Gochi M et al. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. 2012 Kekkaku pmid:23367833
Fujita M et al. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease. 2012 J. Infect. Chemother. pmid:21927844
Dobrick N et al. [Legionnaires disease (legionella pneumonia)]. 2012 Praxis (Bern 1994) pmid:23147600
Sano N et al. Comprehensive Analysis of Bacterial Flora in Postoperative Maxillary Cyst Fluid by 16S rRNA Gene and Culture Methods. 2012 ISRN Dent pmid:22685668
Lambiase A et al. In vitro resistance to macrolides and clindamycin by Group B Streptococcus isolated from pregnant and nonpregnant women. 2012 Infect Dis Obstet Gynecol pmid:22675244
Choi GE et al. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. 2012 Antimicrob. Agents Chemother. pmid:22564831
Lu ZM et al. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. 2012 PLoS ONE pmid:22558275
Raithatha AH and Bryden DC Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease. 2012 Indian J Crit Care Med pmid:22557832
Rudramurthy M et al. Nasal vestibulitis due to Nocardiopsis dassonvillei in a diabetic patient. 2012 J. Med. Microbiol. pmid:22556323
Talebi Bezmin Abadi A et al. Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. 2012 Intern Emerg Med pmid:21437583
Ivetić Tkalčević V et al. Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity. 2012 Inflammation pmid:21336676
Ichiki H et al. [A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease]. 2012 Kekkaku pmid:22993889
Schluger NW Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter? 2012 Am. J. Respir. Crit. Care Med. pmid:23071188
Li K and Haber RM Stevens-Johnson syndrome without skin lesions (Fuchs syndrome): a literature review of adult cases with Mycoplasma cause. 2012 Arch Dermatol pmid:22911206
Yang YH et al. Anti-Helicobacter pylori effects of IgY from egg york of immunized hens. 2012 Lab Anim Res pmid:22474475
Li H et al. [Clarithromycin combined with tanshinone for rhinosinusal and laryngeal radiation injury in patients with nasopharyngeal carcinoma after radiotherapy]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22931614
Lee MR et al. Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii). 2012 J. Clin. Microbiol. pmid:22933592
van de Streek J Reinterpretation of the monohydrate of clarithromycin from X-ray powder diffraction data as a trihydrate. 2012 Acta Crystallogr C pmid:22935507
Grosso F et al. A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin. 2012 Cancer Chemother. Pharmacol. pmid:22484722
Federico A et al. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. 2012 Gastroenterology pmid:22484118
Arora S and Budhiraja RD Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion. 2012 J Adv Pharm Technol Res pmid:22470897
Ablanedo-Terrazas Y et al. Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. 2012 Case Rep Med pmid:22481952
Humphrey B et al. Fitness of Escherichia coli strains carrying expressed and partially silent IncN and IncP1 plasmids. 2012 BMC Microbiol. pmid:22475035
Rozza AL et al. Morphologic and pharmacological investigations in the epicatechin gastroprotective effect. 2012 Evid Based Complement Alternat Med pmid:22666296
Noto MJ and Wheeler AP Macrolides for acute lung injury. 2012 Chest pmid:22553255
Martins TG et al. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. 2012 PLoS ONE pmid:22393444
van Ingen J et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. 2012 Am. J. Respir. Crit. Care Med. pmid:22744719
Legendre DP et al. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. 2012 Pharmacotherapy pmid:22392826
Kobashi Y et al. Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin. 2012 Intern. Med. pmid:22821114
Li Y et al. A data-driven predictive approach for drug delivery using machine learning techniques. 2012 PLoS ONE pmid:22384063
Hong SJ The Role of Mycoplasma pneumoniae Infection in Asthma. 2012 Allergy Asthma Immunol Res pmid:22379599
Morisset J et al. A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin. 2012 Ann. Allergy Asthma Immunol. pmid:22727169
Cavusoglu C et al. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. 2012 New Microbiol. pmid:22378556
Sezikli M et al. Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study. 2012 Gut Liver pmid:22375169
Youn YS and Lee KY Mycoplasma pneumoniae pneumonia in children. 2012 Korean J Pediatr pmid:22375148
Gisbert JP et al. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. 2012 Aliment. Pharmacol. Ther. pmid:22372560
Terada M et al. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. 2012 J. Infect. Chemother. pmid:22020630